for Grindex

Update: 16.05.2022

Last week: 18 week 2022 (02.05.2022 - 08.05.2022)

Last full month: Apr 2022

STRATEGIC VIEW


По результатам апреля рынок ЛС ожидаемо откатился назад, компенсируя аномальный март – -27,1% в категории НПВП и -41,2% по категории Милдродата (в упаковках)

В апреле бренды Grindex продолжают удерживать позиции в своих категориях и расти по доле рынка (+0,2 п.п. Капсикам, +0,4 п.п. Милдронат, +0,1 п.п. Сульфаргин)

Теперь коротко по брендам:

МИЛДРОНАТ

+24,0% volume / +65.2% value (YTD)

Милронат продолжает небольшой поступательный рост в деньгах. На фоне рекламной кампании растут продажи новых sku (#20 и #90)

ВИПРОСАЛ

+ 27,6% volume / + 38,3% value (YTD)

Общие результаты YTD на стабильно высоком уровне

КАПСИКАМ

-2.2% volume / -0.8% value (YTD)

Рост доли рынка в апреле (+0,2 п.п.), но ждем большего от ТВ флайта

СУЛЬФАРГИН

+ 5,0% volume / + 11,6% value (YTD)

Отличная динамика продаж на 17 и 18 неделях по обоим sku

АПИЛАК

+ 2,6% volume / + 32,1% value (YTD)

Без значимых изменений в динамике за прошедшие 3 недели


BRAND PORTFOLIO PERFORMANCE

One-pager

Time period Volume, packs Change, % MS Volume Change, p.p. Value, rur Change, % MS Value Change, p.p. Cat. Volume Change, %
APILAC
WoW 2 077 -3.6% 56.7% 3 984 001 -3.5% 83.0% 1.8 -8.7%
MoM 8 817 -34.6% 53.5% -4.3 4 250 643 -36.0% 81.2% -3 -29.4%
YTD 46 010 2.6% 55.0% -4 21 513 648 32.1% 82.3% 0.9 10.0%
MAT 118 778 -16.6% 54.2% -7 50 842 476 10.7% 80.7% -0.7 -5.8%
KAPSIKAM
WoW 19 321 -0.1% 2.7% 0.1 8 378 215 -0.2% 2.9% 0.2 -4.4%
MoM 169 728 -20.9% 2.7% 0.2 74 220 018 -20.8% 2.9% 0.4 -27.1%
YTD 399 017 -2.2% 2.7% -0.1 169 272 174 -0.8% 2.9% -0.5 0.6%
MAT 1 056 171 -14.2% 2.6% -0.2 437 543 805 -8.5% 2.9% -0.4 -7.4%
MILDRONATE
WoW 80 674 -10.6% 21.9% -0.9 54 283 585 -9.9% 23.5% -0.7 -6.9%
MoM 399 925 -40.3% 22.9% 0.4 269 107 725 -36.4% 24.2% 1.1 -41.2%
YTD 2 082 031 24.0% 16.8% 1.9 1 164 744 998 65.2% 17.9% 3.9 9.8%
MAT 5 199 320 15.1% 17.1% 2.2 2 393 048 134 31.7% 16.3% 2.6 0.4%
SULFARGIN
WoW 2 989 16.6% 0.9% 0.1 1 564 277 17.8% 1.3% 0.2 -1.2%
MoM 11 103 -27.8% 0.8% 0.1 5 749 879 -26.5% 1.1% 0.2 -35.6%
YTD 56 843 5.0% 0.8% 0.1 28 411 279 11.6% 1.1% 0.1 -3.5%
MAT 166 844 -13.8% 0.9% -0.1 82 716 363 -2.9% 1.2% 0 -6.9%
VIPROSAL
WoW 22 159 -2.8% 2.9% 0 9 392 729 -2.5% 3.1% 0.1 -4.4%
MoM 97 455 -35.9% 2.9% -0.4 41 743 859 -36.5% 3.1% -0.2 -27.2%
YTD 511 911 27.6% 3.3% 0.7 211 792 605 38.3% 3.5% 0.6 1.1%
MAT 1 354 192 2.6% 3.2% 0.3 529 924 887 9.9% 3.3% 0.2 -7.2%

YTD

Brand Volume, packs Change, % MS Volume Change, p.p. Value, rur Change, % MS Value Change, p.p. Cat. Volume Change, %
APILAC 46 010 2.6% 55.0% -4 21 513 648 32.1% 82.3% 0.9 10.0%
KAPSIKAM 399 017 -2.2% 2.7% -0.1 169 272 174 -0.8% 2.9% -0.5 0.6%
MILDRONATE 2 082 031 24.0% 16.8% 1.9 1 164 744 998 65.2% 17.9% 3.9 9.8%
SULFARGIN 56 843 5.0% 0.8% 0.1 28 411 279 11.6% 1.1% 0.1 -3.5%
VIPROSAL 511 911 27.6% 3.3% 0.7 211 792 605 38.3% 3.5% 0.6 1.1%

MAT

Brand Volume, packs Change, % MS Volume Change, p.p. Value, rur Change, % MS Value Change, p.p. Cat. Volume Change, %
APILAC 118 778 -16.6% 54.2% -7 50 842 476 10.7% 80.7% -0.7 -5.8%
KAPSIKAM 1 056 171 -14.2% 2.6% -0.2 437 543 805 -8.5% 2.9% -0.4 -7.4%
MILDRONATE 5 199 320 15.1% 17.1% 2.2 2 393 048 134 31.7% 16.3% 2.6 0.4%
SULFARGIN 166 844 -13.8% 0.9% -0.1 82 716 363 -2.9% 1.2% 0 -6.9%
VIPROSAL 1 354 192 2.6% 3.2% 0.3 529 924 887 9.9% 3.3% 0.2 -7.2%

WoW

Brand Volume, packs Change, % MS Volume Change, p.p. Value, rur Change, % MS Value Change, p.p. Cat. Volume Change, %
APILAC 2 077 -3.6% 56.7% 3 984 001 -3.5% 83.0% 1.8 -8.7%
KAPSIKAM 19 321 -0.1% 2.7% 0.1 8 378 215 -0.2% 2.9% 0.2 -4.4%
MILDRONATE 80 674 -10.6% 21.9% -0.9 54 283 585 -9.9% 23.5% -0.7 -6.9%
SULFARGIN 2 989 16.6% 0.9% 0.1 1 564 277 17.8% 1.3% 0.2 -1.2%
VIPROSAL 22 159 -2.8% 2.9% 0 9 392 729 -2.5% 3.1% 0.1 -4.4%

MoM

Brand Volume, packs Change, % MS Volume Change, p.p. Value, rur Change, % MS Value Change, p.p. Cat. Volume Change, %
APILAC 8 817 -34.6% 53.5% -4.3 4 250 643 -36.0% 81.2% -3 -29.4%
KAPSIKAM 169 728 -20.9% 2.7% 0.2 74 220 018 -20.8% 2.9% 0.4 -27.1%
MILDRONATE 399 925 -40.3% 22.9% 0.4 269 107 725 -36.4% 24.2% 1.1 -41.2%
SULFARGIN 11 103 -27.8% 0.8% 0.1 5 749 879 -26.5% 1.1% 0.2 -35.6%
VIPROSAL 97 455 -35.9% 2.9% -0.4 41 743 859 -36.5% 3.1% -0.2 -27.2%

VIPROSAL


VALUE & VOLUME DYNAMICS

VOLUME


VALUE

MS VOLUME

MS VALUE


SKU VOLUME DYNAMICS

VOLUME MAT


VOLUME YTD

VOLUME WoW

VOLUME MoM


KAPSIKAM


BRAND VALUE & VOLUME DYNAMICS

MS VOLUME


MS VALUE

VOLUME

VALUE


SKU VOLUME DYNAMICS

VOLUME MAT


VOLUME YTD

VOLUME WoW

VOLUME MoM


MILDRONATE


VALUE & VOLUME DYNAMICS

VOLUME


VALUE

MS VOLUME

MS VALUE


SKU VOLUME DYNAMICS

VOLUME MAT


VOLUME YTD

VOLUME WoW

VOLUME MoM


SULFARGIN


BRAND VALUE & VOLUME DYNAMICS

MS VOLUME


MS VALUE

VOLUME

VALUE


SKU VOLUME DYNAMICS

VOLUME MAT


VOLUME YTD

VOLUME WoW

VOLUME MoM


APILAC


BRAND VALUE & VOLUME DYNAMICS

MS VOLUME


MS VALUE

VOLUME

VALUE


SKU VOLUME DYNAMICS

VOLUME MAT


VOLUME YTD

VOLUME WoW

VOLUME MoM

REFERENCE

Abbreviations

WoW - Week Over Week Change = Sales of the last week / Sales of the previous week - 1

MoM - Month Over Month Change = Sales of the last full month / Sales of the previous full month - 1

YTD - Year to Date - a period of time beginning the first day of the current calendar year up to the current date

MAT - Moving Annual Total - a period, being any 12 month period ending on the last week

MS - Market Share

Data Sources:

DSM: Sales

Palomars: TRPs

MI: Fact Digital Costs

MI Estimated Costs: TV costs